# Opening the door to a new era: A dual‐chamber leadless pacemaker

**Authors:** Miyo Nakano, Yusuke Kondo, Richard H. Hongo, Hiroyuki Takaoka, Yoshio Kobayashi

PMC · DOI: 10.1002/joa3.70100 · Journal of Arrhythmia · 2025-05-28

## TL;DR

A new leadless pacemaker enables dual-chamber pacing, offering a safer option for patients with high infection risk or limited vascular access.

## Contribution

Introduces a dual-chamber leadless pacemaker that enables atrial and ventricular pacing without transvenous leads.

## Key findings

- The device improves AV synchrony by enabling dual-chamber pacing.
- It presents a potential breakthrough for cardiac rhythm management in high-risk patients.

## Abstract

Dual‐chamber leadless pacing with Aveir DR offers a breakthrough alternative for patients at high risk of infection or with limited vascular access. By enabling both atrial and ventricular pacing without transvenous leads, this technology improves AV synchrony and may revolutionize future cardiac rhythm management, including defibrillation and resynchronization therapies.

## Full-text entities

- **Diseases:** infection (MESH:D007239)
- **Chemicals:** Aveir (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12117376/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12117376/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12117376/full.md

---
Source: https://tomesphere.com/paper/PMC12117376